10-QThe Record
Keros Therapeutics, Inc. files 10-Q
Filed Nov 6, 2024 · 1y ago · Accession 0001664710-24-000091
Plain English
Quarterly report — three-month financials and management discussion.
Read the source below for the full document.
Filing details
- Company
- Keros Therapeutics, Inc.
- Ticker
- KROS
- CIK
- 1664710
- Form type
- 10-Q
- Filing date
- Nov 6, 2024
- Report date
- Sep 30, 2024
- Document
- kros-20240930.htm
- Size
- 4.6 MB